LANDSCAPE CAPITAL MANAGEMENT, L.L.C. - IBERE PHARMACEUTICALS ownership

IBERE PHARMACEUTICALS's ticker is IBERU and the CUSIP is G46843127. A total of 1 filers reported holding IBERE PHARMACEUTICALS in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q4 2022$365,680
+0.7%
36,5680.0%0.05%
+14.9%
Q3 2022$363,000
+1.1%
36,5680.0%0.05%
-2.1%
Q2 2022$359,000
-0.6%
36,5680.0%0.05%
+4.3%
Q1 2022$361,000
-1.4%
36,568
-0.0%
0.05%
-11.5%
Q4 2021$366,0000.0%36,5690.0%0.05%
+2.0%
Q3 2021$366,000
-0.5%
36,5690.0%0.05%
+13.3%
Q2 2021$368,000
+44.9%
36,569
+42.2%
0.04%
+12.5%
Q1 2021$254,00025,7130.04%
Other shareholders
IBERE PHARMACEUTICALS shareholders Q1 2023
NameSharesValueWeighting ↓
Hartree Partners, LP 1,285,000$12,875,700,0003.00%
Wealthspring Capital LLC 231,182$2,317,0000.50%
KRYGER CAPITAL Ltd 385,240$3,860,0000.22%
Schechter Investment Advisors, LLC 210,692$2,111,0000.19%
Sage Mountain Advisors LLC 89,180$894,0000.11%
Context Capital Management, LLC 115,053$1,153,0000.09%
Magnetar Financial LLC 784,909$7,865,0000.08%
ARISTEIA CAPITAL, L.L.C. 350,000$3,507,0000.06%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 36,569$366,0000.05%
Bulldog Investors, LLP 15,000$150,0000.04%
View complete list of IBERE PHARMACEUTICALS shareholders